NASDAQ: SMMT · Biotechnology
Over the past week, Summit Therapeutics (SMMT) racked up about 23 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 38% bullish but is sharply divided: News runs 86% bullish while Reddit sits at just 0%. Wall Street is more constructive, with 10 of 17 analysts rating SMMT a buy.
There is little buzz around SMMT this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 59% buy share sits next to a crowd that ranges from Reddit at 0% to News at 86%. No other tracker puts the two side by side.
17 analysts have weighed in: a Buy consensus: 10 buy calls against 2 sell, with an average 12-month price target of $28.69.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is mixed and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 21 points above the crowd average of 38%, the professionals are more constructive than retail. The split is inside the crowd: News reads 86% bullish while Reddit sits at 0%, a 86-point spread that single-source trackers miss.
Over the 30-day window, Summit Therapeutics (SMMT) buzz held subdued around 36.9 while the price drifted down 4.6% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 3.9M shares. Updated Jul 27, 2026. Over the last 7 trading days, SMMT lost 0.7%. Buzz activity in the recent week averaged 29.7 and was variable, swinging between 13.2 and 36.9. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 9 of the 16 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Buzz, bullish share, the loudest item and the positive / neutral / negative split for every tracked source over the last 7 days.
No Polymarket data for this stock this week.
Query sentiment for SMMT and 1000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live SMMT sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Jul 27, 2026.
Based on aggregated sentiment from Reddit, X and News sources, Summit Therapeutics (SMMT) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 38% bullish across 3 active sources. Those sources contribute 23 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Summit Therapeutics (SMMT) is fairly quiet with 1 mentions across 3 tracked subreddits. The tone is 0% bullish with falling 3-day activity momentum, suggesting cooling attention.
The crowd reads bearish on Summit Therapeutics (SMMT), averaging 38% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 86% bullish and Reddit at 0%, a 86-point spread. On the professional side, 10 of 17 analysts rate SMMT a buy.
Of the 17 analysts covering Summit Therapeutics (SMMT), 10 rate it a buy, 5 a hold and 2 a sell, for a buy consensus. The average price target is $28.69. That puts the street ahead of the crowd, which averages 38% bullish.
Summit Therapeutics (SMMT) sentiment is bearish across all 3 tracked sources. X reads 27% bullish, News reads 86% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
Social sentiment data shows consistently bearish discussion around Summit Therapeutics (SMMT). All 3 tracked sources lean negative, with reddit being the most bearish at 0% bullish. 3-day activity momentum is falling on Reddit, while x activity is rising. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 15 mentions (65% of total volume). News contributes 7 mentions and Reddit contributes 1 mention. Sentiment is bearish across all sources, while x is the only source with rising 3-day activity.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. SMMT's sell signal at 93/100 conviction reflects consistently bearish sentiment across 3 tracked sources. It is a research shortcut, not financial advice.
The SMMT sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
These stocks share a comparable sentiment profile to Summit Therapeutics with similar bullish ratios, signal direction and discussion volume. All 6 peers carry sell signals, pointing to broad bearish pressure rather than an SMMT-specific issue.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key